BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1727121)

  • 1. HDR brachytherapy for carcinoma of the cervix: fractionation considerations.
    Brenner DJ; Hall EJ
    Int J Radiat Oncol Biol Phys; 1992; 22(1):221-2. PubMed ID: 1727121
    [No Abstract]   [Full Text] [Related]  

  • 2. Fractionation is important for HDR cervix cancer brachytherapy.
    Orton CG
    Int J Radiat Oncol Biol Phys; 1992; 22(1):222-3. PubMed ID: 1727122
    [No Abstract]   [Full Text] [Related]  

  • 3. High dose rate brachytherapy in the treatment of cervical carcinoma.
    Stitt JA
    Hematol Oncol Clin North Am; 1999 Jun; 13(3):585-93, vii-viii. PubMed ID: 10432431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The trail of the development of high-dose-rate brachytherapy for cervical cancer in Japan.
    Inoue T
    Jpn J Clin Oncol; 2003 Jul; 33(7):327-30. PubMed ID: 12949057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical investigations and fractionation schemes in the treatment of cervix carcinoma with HDR afterloading at the Centre of Oncology in Gliwice.
    Rattka P
    Sonderb Strahlenther Onkol; 1988; 82():173-6. PubMed ID: 3393982
    [No Abstract]   [Full Text] [Related]  

  • 6. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid involution and mobility of carcinoma of the cervix.
    Lee CM; Shrieve DC; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):625-30. PubMed ID: 14751536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
    Kim WC; Kim GE; Suh CO; Loh JJ
    Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is HDR brachytherapy for carcinoma of the uterine cervix high-throughput but high risk?
    Fowler JF
    Acta Oncol; 1998; 37(2):113-5. PubMed ID: 9636004
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-year results with HDR afterloading in cervix cancer: dependence on fractionation and dose.
    Vahrson H; Römer G
    Sonderb Strahlenther Onkol; 1988; 82():139-46. PubMed ID: 3393979
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix.
    Fu KK; Phillips TL
    Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):791-6. PubMed ID: 2145249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: low dose rate and high dose rate intracavitary brachytherapy in a patient with carcinoma of the cervix.
    Tan LT; Jones B; Freestone G; Dale RG
    Br J Radiol; 1996 Jan; 69(817):84-6. PubMed ID: 8785631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
    Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of late effects after HDR afterloading therapy of cervix carcinoma with the GammaMed II.
    Alberti W; Busch M
    Sonderb Strahlenther Onkol; 1988; 82():151-5. PubMed ID: 3393981
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimization of high-dose-rate intracavitary brachytherapy schedule in the treatment of carcinoma of the cervix.
    Patel FD; Kumar P; Karunanidhi G; Sharma SC; Kapoor R
    Brachytherapy; 2011; 10(2):147-53. PubMed ID: 20685179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
    Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer.
    Stewart AJ; Viswanathan AN
    Cancer; 2006 Sep; 107(5):908-15. PubMed ID: 16874815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated high-dose-rate brachytherapy in the management of uterine cervical cancer.
    Park HC; Suh CO; Kim GE
    Yonsei Med J; 2002 Dec; 43(6):737-48. PubMed ID: 12497657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.